August 2013
Reactions Weekly;8/24/2013, Issue 1466, p10
An abstract of the article "An unusual complication in ulcerative colitis during treatment with azathioprine and infliximab: Isospora belli as 'Casus belli," by J. Stein and colleagues is presented.


Related Articles

  • Azathioprine.  // Reactions Weekly;4/13/2013, Issue 1448, p7 

    The article presents a case study of a man who had hepatic cytolysis during treatment with azathioprine for ulcerative colitis.

  • Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Laharie, D. // Inflammatory Bowel Disease Monitor;2013, Vol. 13 Issue 3, p121 

    A review of the article "Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomized controlled trial," by D. Laharie and colleagues, which appeared in the 2012 issue of "Groupe d'Etudes Thérapeutiques des...

  • Infliximab Therapy for Ulcerative Colitis: Many Unanswered Questions. Present, Daniel H. // American Journal of Gastroenterology;Aug2001, Vol. 96 Issue 8, p2294 

    Introduces the article "Infliximab for Refractory Ulcerative Colitis," by William Y. Chey, Ayub Hussain, Charlotte Ryan, Gregory D. Potter and Ashok Shah.

  • Maintenance infliximab not value for money.  // PharmacoEconomics & Outcomes News;6/23/2012, Issue 656, p13 

    The article discusses a study on the cost effectiveness of episodic infliximab therapy versus maintenance infliximab therapy and standard treatment in ulcerative colitis by S.H. Odes and colleagues, published in the May 19, 2012 issue of "Digestive Week 2012."

  • Infliximab rescue therapy after cyclosporin failure in steroidrefractory ulcerative colitis.  // Inflammatory Bowel Disease Monitor;Apr2009, Vol. 10 Issue 2, p65 

    The article discusses the use of infliximab as a rescue therapy for patients with active ulcerative colitis who have failed on steroids and cyclosporine.

  • Etanercept/infliximab.  // Reactions Weekly;6/22/2013, Issue 1458, p22 

    The article describes the case of a woman in her sixties who developed ulcerative colitis (UC) while receiving anti-tumour necrosis factor (anti-TNF) therapy with infliximab and etanercept for rheumatoid arthritis.

  • A Pooled Analysis of Infections, Malignancy, and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease. Lichtenstein, Gary R; Rutgeerts, Paul; Sandborn, William J; Sands, Bruce E; Diamond, Robert H; Blank, Marion; Montello, Jennifer; Tang, Linda; Cornillie, Freddy; Colombel, Jean-Frédéric // American Journal of Gastroenterology;Jul2012, Vol. 107 Issue 7, p1051 

    OBJECTIVES:The objective of this study was to analyze the safety of long-term infliximab treatment, with/without concomitant immunomodulators, across Crohn's disease (CD) and ulcerative colitis (UC) clinical trials.METHODS:To maximize sample size, we pooled primary safety data across 10 CD or UC...

  • Leczenie biologiczne infliksymabem ci&ecedil;żkiej postaci wrzodziej&acedil;cego zapalenia jelita grubego u dzieci. Szychta, Monika; Kierkuś, Jarosław; D&acedil;dalski, Maciej; Wegner, Agnieszka; Kmiotek, Jakub; Ryżko, Józef // Contemporary Pediatrics, Gastroenterology, Hepatology & Child Fe;2012, Vol. 14 Issue 2, p83 

    Introduction: Ulcerative colitis (UC) in children has a variable clinical course ranging from mild to severe phenotype, that needs infliximab therapy. UC diagnosed in early childhood worsens the prognosis. The second-line therapy con-sists either of cydosporine or infliximab. Treatment of UC...

  • Infliximab.  // Reactions Weekly;6/8/2013, Issue 1456, p20 

    The article presents a case study of a 22-year-old woman who developed Takayasu arteritis after being treated with infliximab for ulcerative colitis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics